Sara Murray, MD
Interventional Cardiology · Robbinsdale, MNNPI 1831118496
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 60.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $2,759 and has fallen 73.3% since, to $737 in 2025.
Across 45 payments — averaging $167.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Medtronic$2K
- Boston Scientific$318
- Abiomed$123
- Penumbra, Inc.$45
- Shockwave Medical, Inc$30
- plus $27 from 1 others
What the payments were for
- Consulting fees$3,27543%
- Speaking & faculty fees$1,20016%
- Travel & lodging$1,25817%
- Food & beverage$1,80324%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 20 | $4,565 |
| Medtronic(2 entities) | 18 | $2,429 |
| Boston Scientific | 3 | $318 |
| Abiomed | 1 | $123 |
| Penumbra, Inc. | 1 | $45 |
| Shockwave Medical, Inc | 1 | $30 |
| Heartflow, Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$2,990
- VenaSeal$1,724
- Ultreon$875
- ClosureFast$325
- COROFLOW$169
- GENERAL - THERAPIES$148
- TYRX$111
- Varithena Administration Pack$105
How this compares
$7,536 in reported general payments places this provider in the 55th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 237 | $248,522 |
| XareltoRivaroxaban | 78 | $109,657 |
| Repatha SureclickEvolocumab | 69 | $58,016 |
| JardianceEmpagliflozin | 27 | $22,734 |
| Metoprolol Succinate | 298 | $5,408 |
| Atorvastatin Calcium | 213 | $2,741 |
| Losartan Potassium | 157 | $2,335 |
| Rosuvastatin Calcium | 129 | $2,164 |
| Furosemide | 186 | $1,601 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 72 | $1,512 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 48 | $1,411 |
| Potassium Chloride | 38 | $1,366 |
| Lisinopril | 136 | $1,234 |
| ClopidogrelClopidogrel Bisulfate | 81 | $1,146 |
| Metoprolol Tartrate | 110 | $1,027 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Robbinsdale
- Sumit PatelRobbinsdale$42K
- Alok MaheshwariRobbinsdale$11K
- Abdisamad IbrahimRobbinsdale$5K
- Thom DahleSaint Cloud$1.1M
- Stephen KiddSaint Cloud$607K
- Brian StegmanSt Cloud$587K
- Emmanouil BrilakisMinneapolis$548K
- Wesley PedersenMinneapolis$493K
- Michael ManolesMinneapolis$201K
- Jay TraverseMinneapolis$198K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.